Member News

2018 ATSE Clunies Ross Award Recepients

2018 ATSE Clunies Ross Entrepreneur of the Year: Dr Erol Harvey FTSE TRANSLATING MICRO AND NANO TECHNOLOGY Scientist, educator and entrepreneur Dr Erol Harvey has made outstanding contributions to Australia through the world-leading microfluidic engineering company MiniFAB, his…

Cynata Announces Research Collaboration with University of New South Wales to Develop Stem Cell Therapies for Coronary Artery Disease

Melbourne, Australia; 18 June 2018: Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce that it has commenced a preclinical research collaboration with UNSW Sydney (the University of New South Wales)…

Prana to commence Phase 1 clinical trial of PBT434 for treatment of parkinsonian diseases

Prana receives ethics committee approval for a clinical trial evaluating first in human dosing of PBT434 Recruitment has commenced for the first cohort of healthy volunteers Study conducted by leading Australian early phase clinical trial facility Nucleus Network,…

Job:  Senior Quality Associate

♦ Professional Growth Opportunity ♦ ASX Listed Pharmaceutical Company ♦ Flexible Working Environment The Company The Company is an Australian-based ASX listed pharmaceutical company that is developing high quality and clinically validated medicines. The Company is bringing together…

“Medicines Development for Global Health Secures U.S. FDA Approval For Moxidectin For The Treatment Of River Blindness”

MELBOURNE, GENEVA, and NEW YORK Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved moxidectin 8…

Job: Board Directors – Anatara Lifesciences

Well-established listed Biotech  Anatara is a LifeSciences Company based in Brisbane and Melbourne which has successfully developed proprietary technology focused on the treatment of gastrointestinal conditions in several animal species. Recently, Anatara signed a worldwide licence with Zoetis…

Piper Alderman Melbourne has relocated

From 4 June 2018 you will find them at Level 23, 459 Collins Street, Melbourne, 3000 Commencing Monday 4 June 2018, the Melbourne office of Piper Alderman will operate from Level 23, 459 Collins Street, Melbourne. This change will see…

Member news: Success story of a patient on GrunBiotic’s Neurofolin

Member news: Success story of a patient on GrunBiotic’s Neurofolin: https://www.mamamia.com.au/folate-depression/”

AdAlta secures key manufacturing agreements for AD-214

AdAlta secures key manufacturing agreements for AD-214 Please click here for an ASX announcement relating to the execution of key manufacturing agreements for AD-214

Walter and Eliza Hall Institute news: Structure of protein pair provides blueprint for future drugs

Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling to dampen immune responses and block cancer growth. The atomic-level structure of SOCS1 binding to its partner protein…

Job: Senior Development Scientist – Cancer Genetics / Epidemiology – Genetic Technologies Limited

Full-Time Position LOCATION: Fitzroy, Melbourne  Genetic Technologies Limited (ASX: GTG) is committed to translating recent advances in disease susceptibility genetics to clinically useful commercial assays for patient risk assessment and management activities. THE ROLE: The present opportunity would ideally…

Job: Research & Project Officer, Committee for Melbourne

About the Committee Committee for Melbourne is all about shaping a better future for Melbourne. Working together with our members, we make a difference by challenging the status quo and encouraging thought leadership to create change through confident and…

Home

News & opinion

Member Directory

Events